CIPHER PHARMACEUTICALS
Cipher Pharmaceuticals is a specialty pharmaceutical company that develops improved formulations of existing drugs. They search for products in defined markets to in-license into our pipeline. These products are based on currently marketed molecules paired with a novel drug delivery technology for enhanced performance. Their core competency is identifying these product opportunities and managing their clinical and regulatory development. Finally, we harvest the rewards by out-licensing to partners and generating royalty streams.
CIPHER PHARMACEUTICALS
Social Links:
Industry:
Health Care Medical Pharmaceutical
Founded:
2000-01-01
Address:
Mississauga, Ontario, Canada
Country:
Canada
Website Url:
http://www.cipherpharma.com
Total Employee:
51+
Status:
Active
Contact:
905-602-5840
Email Addresses:
[email protected]
Total Funding:
20 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Sitelinks Search Box Organization Schema Yoast WordPress SEO Plugin
Similar Organizations
![]()
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
![]()
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
![]()
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Sprout Pharmaceuticals
Sprout Pharmaceuticals is a medical company that develops products for the treatment of female sexual dysfunction.
![]()
Theravance Biopharma
Theravance Biopharma is a biopharmaceutical company with one approved product.
Founder

Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-03-28 | Cardiome Pharma | Cardiome Pharma acquired by Cipher Pharmaceuticals | 25.5 M USD |
| 2015-04-13 | innocutis | innocutis acquired by Cipher Pharmaceuticals | 45.5 M USD |
Investors List
![]()
CIBC
CIBC investment in Post-IPO Debt - Cipher Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-11 | Cipher Pharmaceuticals Strengthens Leadership Team with Appointment of New CFO |
Official Site Inspections
http://www.cipherpharma.com Semrush global rank: 9.98 M Semrush visits lastest month: 70
- Host name: 172.67.210.178
- IP address: 172.67.210.178
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Cipher Pharmaceuticals"
About Cipher Pharmaceuticals - Cipher โฆ
Cipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products.See details»
Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX:CPHRF)
Cipher Pharmaceuticals (TSX: CPH) (OTCQX:CPHRF) is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products.See details»
Cipher Pharmaceuticals Enhances Leadership Team with
Oct 8, 2024 For more information, visit www.cipherpharma.com. Forward-Looking Statements and Non-IFRS Measures This document includes forward-looking statements within the โฆSee details»
Cipher Pharmaceuticals - Crunchbase Company Profile โฆ
Contact Email [email protected] Phone Number 905-602-5840 Cipher Pharmaceuticals is a specialty pharmaceutical company that develops โฆSee details»
Cipher Pharmaceuticals - Overview, News & Similar companies
Aug 11, 2022 Cipher Pharmaceuticals contact info: Phone number: (800) 499-4468 Website: www.cipherpharma.com What does Cipher Pharmaceuticals do? Cipher Pharmaceuticals โฆSee details»
Cipher Pharmaceuticals Inc. Information - RocketReach
Cipherpharma.com; 2 407399XXXX; 407353XXXX; View Similar People. Related Companies Rapid Aid. 42 $20.7m Insception Lifebank Cord Blood Program. 44 $16.1m Natco Pharma โฆSee details»
Cipher Pharmaceuticals Strengthens Leadership Team with
Aug 11, 2022 Experienced finance executive Bryan Jacobs, CPA, CA to join the Company as CFO, effective August 15, 2022.. OAKVILLE, ON, Aug. 11, 2022 /CNW/ - Cipher โฆSee details»
Cipher Pharmaceuticals Inc (CPH-T) Profile - The Globe and Mail
Mar 25, 2014 See the company profile for Cipher Pharmaceuticals Inc (CPH-T) including business summary, industry/sector information, business summary, corporate governance, โฆSee details»
Cipher Pharmaceuticals - Cipher Pharmaceuticals Inc.
Mar. 18, 2025 Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2024 ResultsSee details»
Business Development - Cipher Pharmaceuticals Inc.
We are a high growth, motivated and opportunistic dermatology focused specialty pharmaceutical organization looking forward to business development opportunities. Cipherโs near-term focus, โฆSee details»
Cipher Pharmaceuticals Inc. (CPHRF) Company Profile & Overview
Mar 11, 2025 Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe โฆSee details»
Cipher Pharmaceuticals - Craft
Oct 29, 2024 Cipher Pharmaceuticals has 5 employees at their 1 location and $21.16 m in annual revenue in FY 2023. See insights on Cipher Pharmaceuticals including office locations, โฆSee details»
Cipher Pharmaceuticals Announces the Commencement of โฆ
Jan 29, 2024 For more information, visit www.cipherpharma.com. SOURCE Cipher Pharmaceuticals Inc. [email protected] × Modal title. Organization Profile. Cipher โฆSee details»
Cipher Pharmaceuticals - PitchBook
Cipher Pharmaceuticals General Information Description. Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute โฆSee details»
Cipher Pharmaceuticals Enhances Leadership Team with โฆ
Oct 8, 2024 Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") announced today the appointment of Hamed Ghanei as Chief Business Officer โฆSee details»
Cipher Pharmaceuticals Inc.
You may find further information concerning the Corporation on our website: www.cipherpharma.com. As the COVID-19 situation evolves, any changes in the Meeting โฆSee details»
Cipher Pharmaceuticals Inc, CPHRF:QXE profile - FT.com
Feb 28, 2025 Cipher Pharmaceuticals Inc (CPHRF:QXE) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Cipher Pharmaceuticals Enters into Co-Promotion Agreement
OAKVILLE, ON, Feb. 10, 2021 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced it has entered into an exclusive co-promotion agreement (the โฆSee details»
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2024 โฆ
3 days ago Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced its financial and operating results for the year ended December โฆSee details»
Senior Marketing Manager, Gastroenterology Business
โข 2+ years of experience within a pharmaceutical start up organization (preferred) Qualifications: โข Demonstrated track record of successful product launches and sustained commercial growth โข โฆSee details»